These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
697 related items for PubMed ID: 9427806
21. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells. Johnson-Léger C, Christenson JR, Holman M, Klaus GG. J Immunol; 1998 Nov 01; 161(9):4618-26. PubMed ID: 9794390 [Abstract] [Full Text] [Related]
22. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance. Reipert BM, Sasgary M, Ahmad RU, Auer W, Turecek PL, Schwarz HP. Thromb Haemost; 2001 Dec 01; 86(6):1345-52. PubMed ID: 11776297 [Abstract] [Full Text] [Related]
23. Fas (CD95)/Fas ligand interactions regulate antigen-specific, major histocompatibility complex-restricted T/B cell proliferative responses. Ozdemirli M, El-Khatib M, Foote LC, Wang JK, Marshak-Rothstein A, Rothstein TL, Ju ST. Eur J Immunol; 1996 Feb 01; 26(2):415-9. PubMed ID: 8617312 [Abstract] [Full Text] [Related]
24. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism. Dranitzki-Elhalel M, Huang JH, Sasson M, Rachmilewitz J, Parnas M, Tykocinski ML. Int Immunol; 2007 Apr 01; 19(4):355-63. PubMed ID: 17314083 [Abstract] [Full Text] [Related]
25. Inhibition of B cell expression of DNA polymerase alpha by CD4+ suppressor T cells. Hirohata S. Cell Immunol; 1993 Aug 01; 150(1):159-67. PubMed ID: 8102086 [Abstract] [Full Text] [Related]
26. Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions. Kweon MN, Fujihashi K, Wakatsuki Y, Koga T, Yamamoto M, McGhee JR, Kiyono H. J Immunol; 1999 Feb 15; 162(4):1904-9. PubMed ID: 9973457 [Abstract] [Full Text] [Related]
27. CD40 preferentially costimulates activation of CD4+ T lymphocytes. Cayabyab M, Phillips JH, Lanier LL. J Immunol; 1994 Feb 15; 152(4):1523-31. PubMed ID: 7509825 [Abstract] [Full Text] [Related]
28. CD40 expressed on thymic epithelial cells provides costimulation for proliferation but not for apoptosis of human thymocytes. Ruggiero G, Martinez Cáceres E, Voordouw A, Noteboom E, Graf D, Kroczek RA, Spits H. J Immunol; 1996 May 15; 156(10):3737-46. PubMed ID: 8621909 [Abstract] [Full Text] [Related]
29. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response. Jaiswal AI, Croft M. J Immunol; 1997 Sep 01; 159(5):2282-91. PubMed ID: 9278317 [Abstract] [Full Text] [Related]
30. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells. An S, Yap D, Knox KA. Cell Immunol; 1997 Nov 01; 181(2):139-52. PubMed ID: 9398401 [Abstract] [Full Text] [Related]
31. Cellular and molecular factors that regulate the differentiation and apoptosis of germinal center B cells. Anti-Ig down-regulates Fas expression of CD40 ligand-stimulated germinal center B cells and inhibits Fas-mediated apoptosis. Choe J, Kim HS, Zhang X, Armitage RJ, Choi YS. J Immunol; 1996 Aug 01; 157(3):1006-16. PubMed ID: 8757604 [Abstract] [Full Text] [Related]
32. Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis. Blotta MH, Marshall JD, DeKruyff RH, Umetsu DT. J Immunol; 1996 May 01; 156(9):3133-40. PubMed ID: 8617933 [Abstract] [Full Text] [Related]
33. Co-stimulation by anti-immunoglobulin is required for B cell activation by CD40Llow T cells. Poudrier J, Owens T. Eur J Immunol; 1994 Dec 01; 24(12):2993-9. PubMed ID: 7805727 [Abstract] [Full Text] [Related]
34. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. Wiley JA, Harmsen AG. J Immunol; 1995 Oct 01; 155(7):3525-9. PubMed ID: 7561048 [Abstract] [Full Text] [Related]
35. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. Akiba H, Oshima H, Takeda K, Atsuta M, Nakano H, Nakajima A, Nohara C, Yagita H, Okumura K. J Immunol; 1999 Jun 15; 162(12):7058-66. PubMed ID: 10358148 [Abstract] [Full Text] [Related]
36. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Kennedy MK, Picha KS, Fanslow WC, Grabstein KH, Alderson MR, Clifford KN, Chin WA, Mohler KM. Eur J Immunol; 1996 Feb 15; 26(2):370-8. PubMed ID: 8617306 [Abstract] [Full Text] [Related]
37. Role of CD40 antigen and interleukin-2 in T cell-dependent human B lymphocyte growth. Blanchard D, Gaillard C, Hermann P, Banchereau J. Eur J Immunol; 1994 Feb 15; 24(2):330-5. PubMed ID: 7507843 [Abstract] [Full Text] [Related]
38. Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity. Sad S, Krishnan L, Bleackley RC, Kägi D, Hengartner H, Mosmann TR. Eur J Immunol; 1997 Apr 15; 27(4):914-22. PubMed ID: 9130644 [Abstract] [Full Text] [Related]
39. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells. Urayama S, Kawakami A, Matsuoka N, Tsuboi M, Nakashima T, Kawabe Y, Koji T, Eguchi K. Biochem Biophys Res Commun; 1997 Oct 29; 239(3):782-8. PubMed ID: 9367846 [Abstract] [Full Text] [Related]
40. Frequency of human B cells that differentiate in response to anti-CD3-activated T cells. Amoroso K, Lipsky PE. J Immunol; 1990 Nov 15; 145(10):3155-61. PubMed ID: 2146316 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]